IGF2BP1 and glioblastoma: In glioblastoma multiforme (GBM), PCAT6 could upregulate IGF2BP1 expression by acting as a ceRNA against miR-513, causing a PCAT6/miR-513/IGF2BP1 positive feedback loop that facilitates GBM progression (50).